Global Ablation Devices Market to Reach USD 18,418.79 Million by 2031 | CAGR of 9.4%
Category : Medical Devices | Published Date : Nov 2024 | Type : Press Release
Ablation Devices Market Scope & Overview:
In the newly published report, Consegic Business Intelligence states that the Ablation Devices Market size was valued at USD 9,058.00 million in 2023 and is projected to grow at a CAGR of 9.4%, reaching USD 18,418.79 million by 2031. Ablation devices are advanced medical tools used to destroy abnormal tissues using various energy forms, such as radiofrequency, microwave, or laser energy. These devices are pivotal in minimally invasive procedures, including tumor removal, cardiac arrhythmia treatment, and pain management, providing enhanced precision and faster recovery times.
The report comprises the Ablation Devices Market Share, Size & Industry Analysis, based on Product Type (Radiofrequency Ablation, Cryoablation, Pulsed-Field Ablation, Microwave Ablation, Others), Application (Cardiology, Oncology, Orthopedics, Pain Management, Others), and Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), and Forecast, 2024-2031.
The report contains detailed information on Ablation Devices Market Trends, Opportunities, Value, Growth Rate, Segmentation, Geographical Coverage, Company Profiles, In-depth Expert Analysis, Revenue Forecast, Competitive Landscape, Growth Factors, Restraints or Challenges, Environment & Regulatory Landscape, PESTLE Analysis, PORTER Analysis, Key Technology Landscape, Value Chain Analysis, and Cost Analysis.
Increasing preference for minimally invasive treatments, coupled with rising adoption of catheter-based ablation in aging populations, are major factors propelling market growth.
Segmental Analysis :
Based on product type, the market is segmented into Radiofrequency Ablation, Cryoablation, Pulsed-Field Ablation, Microwave Ablation, and Others.
- The radiofrequency ablation segment accounted for the largest revenue share in 2023, driven by its wide application in cardiac arrhythmias, tumor removal, and chronic pain management. Its precision and minimal invasiveness further contribute to its dominance.
- The pulsed-field ablation segment is projected to grow at the fastest rate during the forecast period, supported by advancements in technology and its superior safety profile for treating cardiac arrhythmias.
Based on application, the market is segmented into Cardiology, Oncology, Orthopedics, Pain Management, and Others.
- The cardiology segment held the largest share in 2023, owing to the rising prevalence of atrial fibrillation and cardiac arrhythmias treated using catheter-based ablation techniques.
- The oncology segment is anticipated to grow at the fastest CAGR, driven by the increasing adoption of ablation therapies for minimally invasive tumor treatments.
Based on regions, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America.
- North America: Dominated the market in 2023, with the U.S. accounting for the highest share, supported by advanced healthcare infrastructure, high prevalence of chronic diseases, and increased adoption of innovative technologies.
- Asia-Pacific: Expected to grow at the fastest CAGR during the forecast period, fueled by increasing healthcare investments, rising adoption of minimally invasive procedures, and a growing geriatric population in countries like China and India.
| Report Attributes | Report Details |
| Study Timeline | 2018-2031 |
| Market Size in 2031 | USD 18,418.79 Million |
| CAGR (2024-2031) | 9.4% |
| Product Type | Radiofrequency Ablation, Cryoablation, Pulsed-Field Ablation, Microwave Ablation, Others |
| Application | Cardiology, Oncology, Orthopedics, Pain Management, Others |
| By Region | North America(U.S., Canada, Mexico) Europe(U.K., Germany, France, Spain, Italy, Russia, Benelux, Rest of Europe) APAC(China, South Korea, Japan, India, Australia, ASEAN, Rest of Asia-Pacific) Middle East & Africa(GCC, Turkey, South Africa, Rest of MEA) LATAM(Brazil, Argentina, Chile, Rest of LATAM) |
Top Key Players & Competitive Landscape :
The ablation devices market is highly competitive, with major players focusing on product innovation, R&D, and strategic collaborations to strengthen their market positions.
List of prominent players in the Ablation Devices Industry:
- Abbott (United States)
- Boston Scientific Corporation (United States)
- Johnson & Johnson Services, Inc. (United States)
- Varian Medical Systems, Inc. (United States)
- Biotronik (Germany)
- Medtronic (United States)
- AngioDynamics (United States)
- EDAT TMS (France)
- Hologic, Inc (United States)
- Avanos Medical, Inc (United States)
Recent Industry Developments :
- November 2024: Johnson & Johnson's Varipulse system received FDA approval for pulsed-field ablation, offering enhanced precision and safety in cardiac procedures.
- July 2024: Stryker launched the MultiGen 2 Radiofrequency Generator for efficient chronic pain management.
- March 2024: Medtronic introduced the Arctic Front Cryoablation System in India, expanding its reach in emerging markets.
